During the last session, Avalo Therapeutics Inc (NASDAQ:AVTX)’s traded shares were 73888.0, with the beta value of the company hitting 1.02. At the end of
Avalo Therapeutics Inc (NASDAQ:AVTX) has a beta value of 0.78 and has seen 1.23 million shares traded in the last trading session. The company, currently
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
